1. Sublobar resection without staging and lymphadenectomy for ≤2 cm Non-Small Cell Lung Cancer is no adequate therapy
   Georg Schlachtenberger et al, 2022, Surgical Oncology CrossRef
2. A commentary on “Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study” (Int J Surg 2020; 84: 25–40)
   Huangkai Zhu et al, 2021, International Journal of Surgery CrossRef
3. Roles of hypoxic environment and M2 macrophage-derived extracellular vesicles on the progression of non-small cell lung cancer
   Xiao Chu et al, 2023, BMC Pulmonary Medicine CrossRef
4. Segmentectomy versus lobectomy for inner-located small-sized early non-small-cell lung cancer
   Shinya Tane et al, 2022, Interactive CardioVascular and Thoracic Surgery CrossRef